Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Ferguson James J. III received 102,400 Mineralys Therapeutics, Inc. shares as an award (Form 4)

Traded Aug 10, 2026 · Filed Aug 12, 2026

On Aug 10, 2026, Ferguson James J. III (Chief Medical Officer) received 102,400 Mineralys Therapeutics, Inc. shares as an award, leaving 102,400 shares. Filed Aug 12, 2026 (Form 4).

Awarded
102,400 shares
Holding after
102,400 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockAward102,400102,400Direct

Source

View original at SEC

Related